← Back to Patent Explorer
US4634665A Expired / Lapsed US ⏱️ 0.0 years remaining

Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials

Assignee: Columbia University
•
Filing: 1983-08-11
•
Granted: 1987-01-06
•
Expires: 2003-08-11
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The present invention relates to processes for inserting DNA into eucaryotic cells, particularly DNA which includes a gene or genes coding for desired proteinaceous materials for which no selective criteria exist. The insertion of such DNA molecules is accomplished by cotransforming eucaryotic cells with such DNA together with a second DNA which corresponds to a gene coding for a selectable marker. This invention also concerns processes for producing proteinaceous materials such as insulin, interferon protein, growth hormone and the like which involve cotransforming eucaryotic cells with DNA which codes for these proteinaceous materials, growing the contransformed cells for production of the proteinaceous material and recovering the proteinaceous material so produced. The invention further relates to processes for inserting into eucaryotic cells a multiplicity of DNA molecules which includes genes coding for desired proteinaceous materials. The insertion of multiple copies of desired genes is accomplished by cotransformation with the desired genes and with amplifiable genes for a dominant selectable marker in the presence of successively higher amounts of an inhibitor. Alternatively, the insertion of multiple copies of desired genes is accomplished by transformation using DNA molecules formed by ligating a DNA molecule including the desired gene to a DNA molecule which includes an amplifiable gene coding for a dominant selectable phenotype such as a gene associated with resistance to a drug in the presence of successively higher amounts of an agent such as a drug against which the gene confers resistance so that only those eucaryotic cells into which multiple copies of the amplifiable gene have been inserted survive. Eucaryotic cells into which multiple copies of the amplifiable gene have been inserted additionally include multiple copies of the desired gene and may be used to produce multiple copies of proteinaceous molecules. In this way otherwise rare proteinaceous materials may be obtained in higher concentrations than are obtainable using conventional techniques.

Inventors

  • 👤 Richard Axel
  • 👤 Michael H. Wigler
  • 👤 Saul J. Silverstein

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 12:18
CPC Classifications
C; C12; C12N; C12N15/00; C12N15/09; C12N15/63; C12N15/79; C12N15/85; C12P; C12P21/00; C12P21/02; Y; Y10; Y10S; Y10S435/00; Y10S435/811; Y10S435/8215; Y10S435/948

Claims Analysis

Total Claims: 25
Claim 1
Independent Claim 74 words
A process for inserting foreign DNA I into a suitable eucaryotic cell which comprises cotransforming said eucaryotic cell with said foreign DNA I and with unlinked foreign DNA II which codes for a selectable phenotype not expressed by said eucaryotic cell, said cotransformation being carried out under suitable conditions permitting survival or identification of eucaryotic cells which have acquired said selectable phenotype, said foreign DNA II being attached to bacterial plasmid or phage DNA.
Claim 2
Dependent Claim 74 words
A process for inserting foreign DNA I into a suitable eucaryotic cell which comprises cotransforming said eucaryotic cell with said foreign DNA I and with unlinked foreign DNA II which codes for a selectable phenotype not expressed by said eucaryotic cell, said cotransformation being carried out under suitable conditions permitting survival or identification of eucaryotic cells which have acquired said selectable phenotype, said foreign DNA II being attached to bacterial plasmid or phage DNA.
Claim 3
Dependent Claim 25 words
A process in accordance with claim 1, wherein the DNA I or KNA II is attached to phage DNA and encapsidated in a phage particle.
Claim 4
Dependent Claim 20 words
A process in accordance with claim 1, wherein the DNA I or DNA II is attached to bacterial plasmid DNA.
Claim 5
Dependent Claim 16 words
A process in accordance with claim 3, wherein the bacterial plasmid DNA is derived from pBR322.
Claim 6
Dependent Claim 24 words
A process in accordance with claim 1, wherein said foreign DNA I codes for proteinaceous material which is not associated with a selectable phenotype.
Claim 7
Dependent Claim 35 words
A process in accordance wirh claim 5, wherein the proteinaceous material which is not associated with a selectable phenotype comprises interferon protein, insulin, a growth hormone, a clotting factor, a viral antigen or an antibody.
Claim 8
Dependent Claim 37 words
A process in accordance with claim 1, wherein said foreign DNA I is present in an amount relative to said DNA II which codes for a selectable phenotype in the range from about 1:1 to about 1000,000:1.
Claim 9
Dependent Claim 27 words
A process in accordance with claim 1, wherein said DNA II which codes for a selectable phenotype comprises the gene for thymidine kinase from herpes simplex virus.
Claim 10
Dependent Claim 23 words
A process in accordance with claim 1, wherein said DNA II which codes for a selectable phenotype comprises the gene for adenine phosphoribousyltransferase.
Claim 11
Dependent Claim 24 words
A process in accordance with claim 1, wherein said DNA II which codes for a selectable phenotype comprises a gene associated with drug resistance.
Claim 12
Dependent Claim 29 words
A process in accordance with claim 10, wherein the gene associated with drug resistance is the gene coding for a mutant dihydrofolate reductase which renders cells resistant to methotrexate.
Claim 13
Dependent Claim 19 words
A eucaryotic cell into which foreign DNA I has been inserted in accordance with the process of claim 1.
Claim 14
Dependent Claim 19 words
A mammalian cell into which foreign DNA I has been inserted in accordance with the process of claim 1.
Claim 15
Dependent Claim 43 words
A process for producing a proteinaceous material which comprises cotransforming a suitable eucaryotic cell in accordance with the process of claim 1, maintaining the cotransformed eucaryotic cell under suitable conditions permitting production of the proteinaceous material and recovering the proteinaceous material so produced.
Claim 16
Dependent Claim 16 words
A process in accordance with claim 14, wherein the suitable eucaryotic cell is a mammalian cell.
Claim 17
Dependent Claim 93 words
A process for producing a proteinaceous material which comprises cotransforming a suitable eucaryotic cell with foreign DNA I which codes for foreign proteinaceous material which is not associated with a selectable phenotype and with unlinked foreign DNA II which codes for a selectable phenotype not expressed by the eucaryotic cell, said cotransformation being carried out under suitable conditions permitting survival or identification of eucaryotic cells which have acquired the selectable phenotype, maintaining or culturing the cotransformed cells under suitable conditions permitting production of the proteinaceous material and recovering the proteinaceous material so produced.
Claim 18
Dependent Claim 93 words
A process for producing a proteinaceous material which comprises cotransforming a suitable eucaryotic cell with foreign DNA I which codes for foreign proteinaceous material which is not associated with a selectable phenotype and with unlinked foreign DNA II which codes for a selectable phenotype not expressed by the eucaryotic cell, said cotransformation being carried out under suitable conditions permitting survival or identification of eucaryotic cells which have acquired the selectable phenotype, maintaining or culturing the cotransformed cells under suitable conditions permitting production of the proteinaceous material and recovering the proteinaceous material so produced.
Claim 19
Dependent Claim 15 words
A process in accordance with claim 16, wherein the eucaryotic cell is a mammaliam cell.
Claim 20
Dependent Claim 30 words
A process in accordance with claim 16, wherein the foreign DNA I is present in an amount relative to DNA II in the range from about 1:1 to about 100,000:1.
Claim 21
Dependent Claim 27 words
A process in accordance with claim 16, wherein the DNA II which codes for a selectable phenotype comprises the gene for thymidine kinase from herpes simplex virus.
Claim 22
Dependent Claim 23 words
A process in accordance with claim 16, wherein the DNA II which codes for a selectable phenotype comprises the gene for adenine phosphoribosyltransferase.
Claim 23
Dependent Claim 24 words
A process in accordance with claim 16, wherein the DNA II which codes for a selectable phenotype comprises a gene associated with drug resistance.
Claim 24
Dependent Claim 29 words
A process in accordance with claim 21, wherein the gene associated with drug resistance is the gene coding for a mutant dihydrofolate reductase which renders cells resistant to methotrexate.
Claim 25
Dependent Claim 21 words
A process in accordance with claim 16, wherein the eucaryotic cell is cotransformed with a multiplicity of foreign DNA I molecules.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1990-01-05 1990-07-07 1991-01-06 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1994-01-05 1994-07-07 1995-01-06 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1998-01-05 1998-07-07 1999-01-06 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag